Jade Biosciences, Inc. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-05
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.
- Notable: Blinded Study of JADE101 · Immunoglobulin A Nephropathy Recruitment opened
- Minor: JADE201 · Rheumatoid Arthritis Trial sites expanded: 3 → 8 locations
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-29 | NCT07902817 A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A Nephropathy | Phase 3 | Recruiting |
Active trials by phase
| Phase 1 | 3 | |
| Phase 2 | 1 | |
| Phase 3 | 1 |
Disease areas by active trials
Get alerts when Jade Biosciences, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.